Navigation Links
Genta Incorporated Announces Third Quarter 2007 Financial Results
Date:11/7/2007

- New Phase 3 trial of Genasense(R) in melanoma opens to global accrual

- Clinical trial opened for G4544 treatment of bone disease

- Named-patient/compassionate-use program ships initial supply

- Appeal filed to review FDA decision on Genasense in CLL - Brief high-dose IV infusions of Genasense well-tolerated in new clinical

trial

BERKELEY HEIGHTS, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) today reported financial results for the third quarter ended September 30, 2007 and provided an update on the significant progress made in its pipeline of clinical development programs.

"The third quarter was noteworthy for a number of key initiatives," commented Dr. Raymond P. Warrell, Jr., Genta's Chairman and Chief Executive Officer. "For Genasense, we initiated patient accrual into our global Phase 3 trial in melanoma, known as AGENDA. We secured FDA allowance of the G4544 oral gallium IND and initiated its first clinical trial. We completed the filing of our NDA appeal to FDA in CLL. We showed that brief high-dose infusions of Genasense were well-tolerated, potentially offering new treatment options and improved convenience for patients. Finally, we recorded the first revenues for Genasense from the named-patient program. These are major accomplishments in ambitious programs that should significantly enhance shareholder value."

AGENDA: A randomized Phase 3 trial of Genasense in advanced melanoma

During the 3rd quarter, the first patients were randomized and treated on the AGENDA trial. This trial seeks to confirm the effectiveness and safety of the Genasense/chemotherapy combination in patients who had the
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... PHILADELPHIA , May 17, 2013 ... disorders; health economics and outcomes research also   to ... SHP, NASDAQ: SHPG ), the global specialty ... in 7 poster presentations at the American Psychiatric Association ... , May 18-22. The data being presented represent ...
(Date:5/17/2013)... May 17, 2013  Serving a region of 650,000 inhabitants ... , Caribbean Imaging and Radiation Therapy (CIRT, Ponce ... with the acquisition of an Elekta Versa HD™ system, the ... offers clinicians the versatility to deliver conventional therapies to treat ... enabling treatment of highly complex cancers that require extreme targeting ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
... Infection Prevention Business, DUBLIN, Ohio, May 12 ... services that improve the safety and,productivity of health ... assets of privately held Enturia, Inc., the manufacturer ... name., ChloraPrep(R) brand products are used widely ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta- based HIV/AIDS ... into a $10 million common,stock purchase agreement with ... The Company may sell up to $10 ... time to time over a 25-month period after ...
Cached Medicine Technology:Cardinal Health Completes Enturia Acquisition 2GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3
(Date:5/19/2013)... Seven-year-old Torin Phillips and his 6-year-old sister, ... effects of autism. The two siblings, who live just ... behavior therapy (ABA) from the Center for Autism ... most effective treatment centers using evidence-based, state-of-the-art therapy. , ... or answer to his name, and had little interest ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 At ... National Council of Asian Pacific Physicians (NCAPIP), the ... the National Association of Chronic Disease Directors (NACDD), ... of health systems, diabetes, and non-communicable diseases (NCDs) ... The assessment, published in the Hawaii Journal of ...
(Date:5/19/2013)... PHILADELPHIA ─ Gourmands and foodies everywhere have long recognized ... peppery zing to both sweet and savory dishes; now, ... components of the spicy root also may have properties ... results of the study will be presented at the ... bronchoconstriction, a tightening of the bronchial tubes that carry ...
(Date:5/19/2013)... Minnesota (PRWEB) May 19, 2013 People in ... the summer. Altman Fitness is offering its 28 Day Fat ... the program from the comfort of their own home. The ... upon purchase. More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ ... want to leave their houses now, but after using the ...
(Date:5/19/2013)... 2013 Today, Zane Benefits, Inc. ... health insurance . Zane Benefits, which provides comprehensive ... benefits, is the leader in health care reform, ... arrangements . , According to Zane Benefits’ website, ... know the value of small business health insurance ...
Breaking Medicine News(10 mins):Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 2Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 3Health News:Boston Brother and Sister Battle Odds to Overcome Autism with Help from Center for Autism and Related Disorders 4Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3
... medical officer; Pam Lux vice president of internal and ... health management , EAGAN, Minn., Oct. 12 ... announces three new leaders at the organization. Gregory Gilmet, ... Lux is vice president of internal and external communications, ...
... understanding can occur 3 years before diagnosis, study finds ... to perceive relationships between objects (visuospatial skills) may decline ... a new study suggests. , It included 444 people ... study and underwent tests on a number of cognitive ...
... CDPHP announced ... Warren, and Essex - to complement its growing service area. Medicare beneficiaries in these counties ... , ... October 12, 2009 -- CDPHP announced the expansion of its Medicare Choices ...
... Iowa, Oct. 12 The Iowa Committee for Value ... principles for high-value, fiscally responsible health care that Congress ... discussions over national reform. , The committee found that ... of the principles for value-based reform. Health care providers, ...
... kicking nicotine addiction , MONDAY, Oct. 12 (HealthDay News) -- ... million grant to a Maryland company to help it in ... , Nabi Biopharmaceuticals of Rockville will launch a phase ... which could be the last step of research if the ...
... ... Trends , ... WA (Vocus) October 12, 2009, , ,MEDIA ALERT, , ,WHO: More than 5,000 ... , , ,WHAT: Plastic Surgery 2009, the American Society of Plastic Surgeons (ASPS) ...
Cached Medicine News:Health News:Blue Cross Names Three New Executives 2Health News:Blue Cross Names Three New Executives 3Health News:Drop in Certain Visual Skills May Precede Alzheimer's 2Health News:CDPHP Medicare Choices Expands Service Area Northward 2Health News:CDPHP Medicare Choices Expands Service Area Northward 3Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 2Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 3Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 4Health News:Iowa Committee Makes Recommendations to Increase Value in Health Care 5Health News:Stop-Smoking Vaccine in the Works 2Health News:American Society of Plastic Surgeons Annual Meeting Photo Op 2Health News:American Society of Plastic Surgeons Annual Meeting Photo Op 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: